AstraZeneca signs on as for Susan G. Komen for the Cure
Participating in this sponsorship deal:
About Sponsor:
AstraZeneca plc is a global pharmaceutical and biologics company headquartered in London, United Kingdom. It is the world's seventh-largest pharmaceutical company measured by revenues and has operations in over 100 countries. It has a portfolio of products for major disease areas including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation.
About Property:
Susan G. Komen for the Cure, formerly known as The Susan G. Komen Breast Cancer Foundation, often referred to as simply Komen, is the most widely known, largest and best-funded breast cancer organization in the United States.[1] Since its inception in 1982, Komen has spent (through 2010) nearly $1.5 billion[2] for breast cancer research, education, advocacy, health services and social support programs in the U.S.,[3] and through partnerships in more than 50 countries.[4][5] Today, Komen has more than 100,000 volunteers[6] working in a network of 124 affiliates worldwide.[7]